16

Vincent Medical Holdings LtdHKG 1612 Stock Report

Last reporting period 30 Jun, 2023

Updated 12 Nov, 2024

Last price

Market cap $B

0.036

Micro

Exchange

XHKG - Hong Kong Exchange

1612.HK Stock Analysis

16

Neutral

Based on Eyestock quantitative analysis, 1612.HK`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

80/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

87.0 %

Undervalued

Market cap $B

0.036

Dividend yield

10.12 %

Shares outstanding

653.34 B

Vincent Medical Holdings Ltd. engages in the manufacture and sale of medical devices. The company employs 1,248 full-time employees The company went IPO on 2016-07-13. The firm and its subsidiaries are principally engaged in the research, development, manufacture and trade of medical devices. The Company’s products include respiratory products, Orthopaedics & Rehabilitation Products and other medical devices. The Company’s subsidiaries includes Vincent Medical Manufacturing Holdings Limited, Vincent Medical Care Holdings Limited, Vincent Medical (GuangZhou) R&D Limited, VINCENT HEALTHCARE PRODUCTS LIMITED, VINCENT MEDICAL CARE COMPANY LIMITED, Vincent Medical (Dongguan) Mfg. Co. LTD., as well as VINCENT MEDICAL MANUFACTURING CO., LIMITED, among others.

View Section: Eyestock Rating